Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.18B |
| 2 |
Apple
AAPL
|
+$1.11B |
| 3 |
Broadcom
AVGO
|
+$562M |
| 4 |
Amazon
AMZN
|
+$553M |
| 5 |
Palo Alto Networks
PANW
|
+$485M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$246M |
| 2 |
O'Reilly Automotive
ORLY
|
+$149M |
| 3 |
Cadence Design Systems
CDNS
|
+$149M |
| 4 |
Synopsys
SNPS
|
+$134M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.24% |
| 2 | Healthcare | 13.33% |
| 3 | Financials | 12.09% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Lightbridge
LTBR
$271M
| $832K | ﹤0.01% |
142,990
+51,619
| +56% | +$228K |
|
3427
AstroNova
ALOT
$225M
| $831K | ﹤0.01% |
57,286
| – | – |
|
|
CBIO
3428
Crescent Biopharma
CBIO
$537M
| $829K | ﹤0.01% |
4,762
+709
| +17% | +$119K |
|
|
MRUS
3429
DELISTED
Merus
MRUS
| $826K | ﹤0.01% |
31,371
+6,601
| +27% | +$145K |
|
|
NAGE
3430
Niagen Bioscience
NAGE
$271M
| $823K | ﹤0.01% |
524,399
-33,036
| -6% | -$49.3K |
|
3431
Peoples Bancorp of North Carolina
PEBK
$229M
| $823K | ﹤0.01% |
45,151
+3,601
| +9% | +$82K |
|
3432
Crawford & Co Class B
CRD.B
$491M
| $822K | ﹤0.01% |
87,575
-6,105
| -7% | -$52K |
|
|
CDTX
3433
DELISTED
Cidara Therapeutics
CDTX
| $822K | ﹤0.01% |
36,386
+3,403
| +10% | +$80K |
|
3434
Union Bankshares
UNB
$106M
| $822K | ﹤0.01% |
35,814
| – | – |
|
|
NOTV
3435
DELISTED
Inotiv
NOTV
| $820K | ﹤0.01% |
171,969
-227,099
| -57% | -$1.25M |
|
3436
Byrna Technologies
BYRN
$103M
| $820K | ﹤0.01% |
163,711
-8,735
| -5% | -$47.1K |
|
3437
Eagle Bancorp Montana
EBMT
$187M
| $807K | ﹤0.01% |
61,019
+9,762
| +19% | +$129K |
|
3438
Taboola.com
TBLA
$1.37B
| $803K | ﹤0.01% |
258,061
+80,445
| +45% | +$220K |
|
3439
Acumen Pharmaceuticals
ABOS
$155M
| $802K | ﹤0.01% |
166,820
| – | – |
|
|
SOND
3440
DELISTED
Sonder
SOND
| $799K | ﹤0.01% |
75,298
-79,363
| -51% | -$860K |
|
3441
DiaMedica Therapeutics
DMAC
$342M
| $799K | ﹤0.01% |
184,870
| – | – |
|
3442
Acme United Corp
ACU
$217M
| $798K | ﹤0.01% |
31,998
-333
| -1% | -$8.44K |
|
|
MVLA
3443
DELISTED
Movella Holdings Inc. Common Stock
MVLA
| $797K | ﹤0.01% |
374,201
+356,407
| +2,003% | +$676K |
|
|
CTV
3444
DELISTED
Innovid Corp.
CTV
| $796K | ﹤0.01% |
730,180
-646,673
| -47% | -$671K |
|
|
CONX
3445
DELISTED
CONX Corp. Class A Common Stock
CONX
| $792K | ﹤0.01% |
76,934
+247
| +0.3% | +$2.54K |
|
3446
SB Financial Group
SBFG
$164M
| $790K | ﹤0.01% |
62,419
| – | – |
|
3447
Neonode
NEON
$14.1M
| $787K | ﹤0.01% |
97,444
+8,884
| +10% | +$66.3K |
|
|
ENER
3448
DELISTED
Accretion Acquisition Corp
ENER
| $786K | ﹤0.01% |
75,543
+456
| +0.6% | +$4.71K |
|
3449
Pixelworks
PXLW
$38.2M
| $785K | ﹤0.01% |
37,796
-2,360
| -6% | -$45.5K |
|
3450
Corvus Pharmaceuticals
CRVS
$1.12B
| $783K | ﹤0.01% |
342,079
+44,279
| +15% | +$92K |
|
Similar funds
Geode Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Geode Capital Management held 4,889 positions worth $851B, up 11% from $770B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 4.4%. Geode Capital Management opened 83 new positions and exited 132, leaving the 4,889-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2023 buy was Coupang: 4,567,454 shares worth $79.5M.
- Geode Capital Management added most to Microsoft in Q2 2023, an estimated $1.18B increase.
- Geode Capital Management's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $246M.
- Geode Capital Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $111M.
- Geode Capital Management's ten largest holdings make up 26% of its $851B portfolio in Q2 2023.
- Geode Capital Management opened 83 new positions and closed 132 in Q2 2023.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $851B.
Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.